Original Article. Urinary Tract Desobstruction in Patients with Malignant Neoplasms of the Uterine Cervix

1. Valerianova Z, Dimitrova N, Vukov M, Atanasov E, editors. Cancer incidence in Bulgaria 2013. Sofia: Paradigma; 2015.Search in Google Scholar

2. Goldfarb RA, Fan Y, Jarosek S, Elliott SP. The burden of chronic ureteral stenting in cervical cancer survivors. Int Braz J Urol. 2016. doi: 10.1590/S1677-5538.IBJU.2016.0667. [Epub ahead of print] Pub Med PMID: 27649113.Search in Google Scholar

3. Goodwin WE, Casey WC,Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc. 1955;157:891-4.10.1001/jama.1955.02950280015005Search in Google Scholar

4. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral stents inserted cystoscopically. J Urol. 1967;97:840-4.10.1016/S0022-5347(17)63130-6Search in Google Scholar

5. Chitale SV, Scott-Barrett S, Ho ET, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol. 2002;57:1118-21.10.1053/crad.2002.1114Search in Google Scholar

6. Lee SK, Jones HW 3 . rd Prognostic significance of ureteral obstruction in primary cervical cancer. Int J Gynecol Obstet. 1994;44:59-65.10.1016/0020-7292(94)90024-8Search in Google Scholar

7. Dyer RB, Regan JD, Kavanagh PV, Khatod EG, Chen MY, Zagoria RJ. Percutaneous nephrostomy with extensions of the technique: step by step. Radiographics. 2002;22(3):503-25.10.1148/radiographics.22.3.g02ma1950312006684Search in Google Scholar

8. Wilson JR, Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction.Ann RColl Surg Engl. 2005;87(1):21-4.10.1308/1478708051432196383015720902Search in Google Scholar

9. Romero FR, Broglio M, Pires SR, Roca RF, Guibu IA, Perez MD. Indications for percutaneous nephrostomy in patients with obstructive uropathy due to malignant urogenital neoplasias. Int Braz J Urol. 2005;31(2):117-24. 10.1590/S1677-55382005000200005Search in Google Scholar